Emedastine difumarate
CAS: 87233-62-3
Ref. 3D-FE29600
| 1g | Descontinuado | ||
| 2g | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
Emedastine difumarate
Sinónimos:
- 1-(2-Ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate
- 1-(2-Ethoxyethyl)-2-(4-methylhexahydro-1H-1,4-diazepin-1-yl)benzimidazole fumarate (1:2)
- 1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole fumarate (1:2)
- 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole di[(2E)-but-2-enedioate]
- 1H-1,4-Diazepine, 1H-benzimidazole deriv.
- 1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-, (2E)-2-butenedioate (1:2)
- 1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-, (E)-2-butenedioate (1:2)
- Al 3432A
- Benzimidazole, 1-(2-ethoxyethyl)-2-(4-methylhexahydro-1H-1,4-diazepin-1-yl)-, fumarate (1:2)
- Emadine
- Ver mais sinónimos
- Emedastine
- Kb-2413
- Kg-2413
- Ly 188695
- Rapimine
- Unii-42Mb94Qosm
- EMEDASTINE FUMARATE
Descrição:
Emedastine difumarate is a 2-adrenergic receptor antagonist that is used as an antihistamine. It has been shown to be effective in the treatment of allergic rhinitis and chronic idiopathic urticaria. Emedastine difumarate binds to histamine H1 receptors on the surface of mast cells and basophils, which inhibits the release of pro-inflammatory mediators, such as eosinophil cationic protein, chemiluminescence, and prostaglandins. This drug also blocks the activation of leukocytes that are involved in allergic reactions. Emedastine difumarate has been shown to be effective against seasonal allergies when administered before exposure to allergens and has a long-term efficacy.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
534.56 g/mol
Fórmula:
C17H26N4O•(C4H4O4)2
Pureza:
Min. 95%
Cor/forma:
Powder
InChI:
InChI=1S/C17H26N4O.2C4H4O4/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20;2*5-3(6)1-2-4(7)8/h4-5,7-8H,3,6,9-14H2,1-2H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1+
Chave InChI:
InChIKey=FWLKKPKZQYVAFR-LVEZLNDCSA-N
SMILES:
CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
